NCT07268261 Combined Method of Surgical Treatment of Anal Fissure
| NCT ID | NCT07268261 |
| Status | Recruiting |
| Phase | — |
| Sponsor | State Scientific Centre of Coloproctology, Russian Federation |
| Condition | Chronic Anal Fissure |
| Study Type | INTERVENTIONAL |
| Enrollment | 122 participants |
| Start Date | 2023-09-01 |
| Primary Completion | 2025-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 122 participants in total. It began in 2023-09-01 with a primary completion date of 2025-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to improve treatment outcomes for patients with chronic anal fissure.
Eligibility Criteria
Inclusion Criteria: * • Patients with chronic anal fissure with spasm of anal sphincter Exclusion Criteria: * • Inflammatory diseases of the colon * Pectenosis * Previous surgical interventions on the anal canal * IV grade internal and external hemorrhoids * Rectal fistula * Severe somatic diseases at the decompensation stage * Pregnancy and lactation * Anal sphincter insufficiency * Chronic paraproctitis * Individual intolerance and hypersensitivity to botulinum toxin * Myasthenia gravis and myasthenic syndromes * History of allergic reaction to anticoagulants. * Blood diseases (thrombocytopenia, splenomegaly, etc.)
Contact & Investigator
Sergey A. Frolov, Ph.D
PRINCIPAL INVESTIGATOR
State Scientific Centre of Coloproctology, Russian Federation (SSCCRussia)
Frequently Asked Questions
Who can join the NCT07268261 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Chronic Anal Fissure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07268261 currently recruiting?
Yes, NCT07268261 is actively recruiting participants. Contact the research team at drzharkov@mail.ru for enrollment information.
Where is the NCT07268261 trial being conducted?
This trial is being conducted at Moscow, Russia.
Who is sponsoring the NCT07268261 clinical trial?
NCT07268261 is sponsored by State Scientific Centre of Coloproctology, Russian Federation. The principal investigator is Sergey A. Frolov, Ph.D at State Scientific Centre of Coloproctology, Russian Federation (SSCCRussia). The trial plans to enroll 122 participants.